The utilization of nanotechnology in cancer treatment offers some energizing prospects, including the chance of wrecking disease tumors with negligible harm to solid tissue and organs, just as the identification and disposal of malignant growth cells before they structure tumors. Over the previous decade, along with the improvement of conventional malignant growth medicines, advantageously planned (regarding their size, shape, fundamental material, and covering) and explicitly focused on nanovehicles have been created. Nano-sized transporters can be functionalized to perceive key structures communicated in disease cells as well as their encompassing tissues. As of late, some increasingly mind boggling frameworks have been built up that misuse the human body's own correspondence frameworks to improve their viability.
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Editorial: Immunochemistry & Immunopathology
Editorial: Immunochemistry & Immunopathology
Commentary: Immunochemistry & Immunopathology
Commentary: Immunochemistry & Immunopathology
Case Report: Immunochemistry & Immunopathology
Case Report: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Keynote: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Immunochemistry & Immunopathology received 174 citations as per Google Scholar report